SCHEMBL19921111

SCHEMBL19921111

CC(C)Sc1ccccc1CNc1nc(N)nc2ccn(-c3ccc(S(N)(=O)=O)cc3)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 8/20 0.35
▸ HTR2A P28223 3/20 0.35
▸ CA1 P00915 5/20 0.34
▸ CA2 P00918 5/20 0.34
▸ CA9 Q16790 5/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19921098 0.85 CA1 (0.35) CA1CA2CA9CA12CLK2
SCHEMBL20546906 0.85 TLR7 (0.35) TLR7HTR2ACA1CA2CA9
SCHEMBL20546907 0.83 STAT6 (0.38) TLR7HTR2ACA1CA2CA9
SCHEMBL20546911 0.78 PDE5A (0.47) CA1CA2CA9CA12
SCHEMBL19921169 0.78 ALDH1A1 (0.40) CA1CA2CA9CA12KDM4E
SCHEMBL19921172 0.76 CYP2D6 (0.41) TLR7CA1CA2CA9CA12
SCHEMBL20546925 0.73 HTR6 (0.38) TLR7HTR2AKCNH2
SCHEMBL20546930 0.73 CDK7 (0.39) —
SCHEMBL20546889 0.72 JAK2 (0.38) CA1CA2CA9CA12KDM4E
SCHEMBL19921116 0.70 IRAK4 (0.40) CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290420-B1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF UNIV XIAMEN (CN) 2020-12-09 — — EP claimed
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF XIAMEN UNIVERSITY (CN) 2018-11-01 — — US claimed
EP-3290420-A1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF Xiamen University (CN) 2018-03-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF TPMT, DHPS, TYMP TLR7 1744/4885HTR2A 2718/4885CA1 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback